Results 71 to 80 of about 7,537 (182)
Impact of Neostigmine and Sugammadex on Time to Leaving the Operating Room in a Community Hospital [PDF]
, 2020 Purpose: The purpose of this study was to evaluate the impact of sugammadex on operating room (OR) times versus neostigmine in patients recovering from rocuronium or vecuronium induced neuromuscular blockade.
Asonganyi, Nicole +7 more
core +2 more sources
BMC Anesthesiology, 2019 Background The use of neostigmine after neuromuscular blockade (NMB) has been associated with postoperative respiratory complications. In previous studies, we found lower diaphragmatic activity after neostigmine reversal of NMB, compared to sugammadex ...
Tom Schepens +6 more
doaj +1 more source
SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation [PDF]
, 2020 Background: Rapid neuromuscular block reversal at the end of major abdominal surgery is recommended to avoid any postoperative residual block. To date, no study has evaluated sugammadex performance after rocuronium administration in patients undergoing ...
Barbariol, F. +4 more
core +1 more source
Effects of sugammadex and rocuronium on electro-mechanical activity of cardiac myocytes [PDF]
Korean Journal of AnesthesiologyBackground Sugammadex reverses the effects of steroidal neuromuscular-blocking agents, such as rocuronium, by encapsulating these agents. Its cardiovascular adverse effects include QTc prolongation, hypotension, bradycardia, atrioventricular block ...
Oguzhan Arun +6 more
doaj +1 more source
Health Economics Review, 2020 Background Neuromuscular blockade and pneumoperitoneum (PP) are important factors to ensure successful laparoscopic surgery. However, residual neuromuscular blockade (rNMB) and PP are associated with many unfavorable complications.
Maodong Ren +5 more
doaj +1 more source
Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports
BMC Anesthesiology, 2019 Background Sugammadex is a modified gamma-cyclodextrin that acts by selectively encapsulating free amino-steroidal neuromuscular relaxants. Several case reports have been published on the use of sugammadex in patients with neuromuscular disorders that ...
Usha Gurunathan +2 more
doaj +1 more source
Analysis of Clinical Outcomes and Cost-Effectiveness of Neuromuscular Blocking Drug Reversal in Patients with Obstructive Sleep Apnea [PDF]
, 2022 Non-depolarizing neuromuscular blockers are used during many surgical procedures to induce muscle relaxation for tracheal intubation and improve surgical conditions for surgeons. The use of these medications requires an agent to be given to fully reverse
Corn, Aaron Mitch, Kinglsey, Samantha
core +1 more source
Caracterização da Utilização de Sugamadex no Centro Hospitalar de Lisboa Central - Hospital de S. José [PDF]
, 2015 Introdução O sugamadex é uma gama ciclodextrina modificada que forma um complexo com os bloqueadores neuromusculares rocurónio e vecurónio, revertendo o bloqueio neuromuscular (BNM) induzido por estes fármacos1,2,3,4.
Antas, T +4 more
core
Sugammadex-Enhanced Neuronal Apoptosis following Neonatal Sevoflurane Exposure in Mice
Anesthesiology Research and Practice, 2016 In rodents, neonatal sevoflurane exposure induces neonatal apoptosis in the brain and results in learning deficits. Sugammadex is a new selective neuromuscular blockade (NMB) binding agent that anesthesiologists can use to achieve immediate reversal of ...
Maiko Satomoto +3 more
doaj +1 more source
BMC Anesthesiology, 2018 Background Previous studies have shown that sugammadex resulted in the prolongation of prothrombin time and activated partial thromboplastin time. In this study, we aimed to investigate the in vitro effects of exogenous sugammadex on the coagulation ...
Il Ok Lee +5 more
doaj +1 more source